Does famciclovir cause fetal abnormalities?
Animal studies show famciclovir and its active metabolite penciclovir cause developmental toxicity, including decreased fetal body weight, skeletal variations, and increased fetal loss at exposures similar to or slightly above human levels.[1][2] No adequate human data exist on use during pregnancy, so fetal risks remain unknown.[1]
What do pregnancy registries and human studies say?
Limited human case reports and postmarketing data report no clear pattern of fetal abnormalities linked to famciclovir, but sample sizes are too small for conclusions.[1][3] The drug's label notes insufficient evidence to assess risks, with penciclovir (famciclovir's metabolite) showing genotoxic potential in tests, raising theoretical concerns for fetal DNA.[1]
FDA pregnancy category and recommendations
Famciclovir carries an FDA Pregnancy Category B rating, meaning no evidence of risk in animal studies at human-equivalent doses, but inadequate controlled human trials prevent ruling out harm.[1] ACOG and CDC advise against routine use in pregnancy unless benefits outweigh potential risks, preferring alternatives like acyclovir for herpes infections.[4][5]
How does it compare to acyclovir or valacyclovir?
Famciclovir converts to penciclovir, which is structurally similar to acyclovir's metabolite but lacks acyclovir's extensive pregnancy safety data (Category B with large registries showing no increased malformation risk).[1][4] Valacyclovir, a prodrug of acyclovir, has a stronger safety profile in pregnancy.[5] Guidelines favor these over famciclovir for pregnant patients.[4]
What if taken accidentally during pregnancy?
Report exposure to the pregnancy registry at 800-336-2176 (U.S.) or consult a teratogen specialist.[1] Monitor via ultrasound for growth and anomalies; no specific antidote exists.[3] Risks may depend on trimester, dose, and duration—first trimester carries highest theoretical concern due to organogenesis.[2]
Sources:
[1] Famciclovir prescribing information, Novartis, DailyMed.
[2] FDA label review, AccessData FDA.
[3] Briggs' Drugs in Pregnancy and Lactation, 11th ed.
[4] CDC Herpes Guidelines, CDC.gov.
[5] ACOG Practice Bulletin on Genital Herpes, ACOG.org.